| Category: |
Antibody |
| Concentration: |
2ml sterile DI water, 5mg/ml if reconstituted with 0 |
| Form: |
Antigen affinity purified |
| Conjugation: |
Unconjugated |
| Clone: |
Polyclonal antibody |
| Recognised antigen: |
SMAD7 |
| Host animal: |
Rabbit (Oryctolagus cuniculus) |
| Clonality: |
Polyclonal (rabbit origin) |
| Species reactivity: |
Due to limited knowledge and inability to test the antibody against all known species, Mouse (Mus musculus), Rat , we cannot guarantee that no other cross reactivity can occur, Human (Homo sapiens) |
| Tested applications: |
IHC-P, WB |
| Recommended dilutions: |
5-1ug/ml, 5-1ug/ml, IHC (Paraffin): 0, Western blot: 0 |
| Notes: |
Titration of the SMAD7 antibody may be required due to differences in protocols and secondary/substrate sensitivity, The stated application concentrations are suggested starting amounts |
| Intented use: |
This SMAD7 antibodyis to be used only for research purposes and not for diagnostics |
| Uniprot #: |
O15105 |
| Purity: |
Antigen affinity |
| Description: |
By FISH, By somatic cell hybrid analysis, It belongs to the SMAD family of proteins, Lallemand et al, Roijer et al, SMAD7 was induced in cultured vascular endothelium by fluid mechanical forces and was capable of modulating endothelial gene expression in response to both humoral and biomechanical stimuli in vitro, TNFA, Topper et al, Topper et al, also known as MADH7 or SMA- AND MAD-related protein 7, is a protein that in humans is encoded by the SMAD7 gene, or loss of cell adhesion, serum withdrawal, which belong to the TGFbeta superfamily of ligands, (1997) demonstrated that SMAD7 and SMAD6 could form complexes in endothelial cells, (1997) mapped the gene to human chromosome 18, (1998) refined the localization to 18q21, (2001) showed that cells stably expressing SMAD7 had increased susceptibility to apoptosis induced by TGFB, 1, Mother against decapentaplegic drosophila homolog of 7 |
| Immunogen: |
mouse and rat), An amino acid sequence from the C-terminus of human SMAD7 (YSLQRPNDHEFMQQP) was used as the immunogen for this SMAD7 antibody (100% homologous in human |
| Storage: |
Avoid repeated freezing and thawing, Celcius or lower, Cycles of freezing and thawing can denaturate the peptide chains of the antibodies and reduce their sensitivity and/or change their affinity, For long-term, Prepare aliqotes in such a manner so that freeze-thaw cycles are minimized, aliquot and store at -20 deg, the SMAD7 antibody can be stored for up to one month at 4oC, After reconstitution |
| Properties: |
C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by NJS poly they should be stored frozen at - 24° |
| Gene target: |
SMAD7 |
| Short name: |
SMAD7 Antibody |
| Technique: |
antibodies against human proteins, antibodies for, Antibody |
| Alternative name: |
SMAD family member 7 (Antibody to) |
| Alternative technique: |
antibodies |
| Alternative to gene target: |
CRCS3 and MADH7 and MADH8, DNA-templated and biological process this GO :0006355 and regulation of transcription, DNA-templated and biological process this GO :0006367 and transcription initiation from RNA polymerase II promoter and biological process this GO :0007179 and transforming growth factor beta receptor signaling pathway and biological process this GO :0008013 and beta-catenin binding and molecular function this GO :0010467 and gene expression and biological process this GO :0010719 and negative regulation of epithelial to mesenchymal transition and biological process this GO :0010801 and negative regulation of peptidyl-threonine phosphorylation and biological process this GO :0010944 and negative regulation of transcription by competitive promoter binding and biological process this GO :0016342 and catenin complex and cellular component this GO :0017015 and regulation of transforming growth factor beta receptor signaling pathway and biological process this GO :0022409 and positive regulation of cell-cell adhesion and biological process this GO :0030336 and negative regulation of cell migration and biological process this GO :0030509 and BMP signaling pathway and biological process this GO :0030512 and negative regulation of transforming growth factor beta receptor signaling pathway and biological process this GO :0030514 and negative regulation of BMP signaling pathway and biological process this GO :0030617 and transforming growth factor beta receptor, DNA-templated and biological process this GO :0045944 and positive regulation of transcription from RNA polymerase II promoter and biological process this GO :0046872 and metal ion binding and molecular function this GO :0048185 and activin binding and molecular function this GO :0048844 and artery morphogenesis and biological process this GO :0050821 and protein stabilization and biological process this GO :0051444 and negative regulation of ubiquitin-protein transferase activity and biological process this GO :0055010 and ventricular cardiac muscle tissue morphogenesis and biological process this GO :0055117 and regulation of cardiac muscle contraction and biological process this GO :0060373 and regulation of ventricular cardiac muscle cell membrane depolarization and biological process this GO :0060389 and pathway-restricted SMAD protein phosphorylation and biological process this GO :0060394 and negative regulation of pathway-restricted SMAD protein phosphorylation and biological process this GO :0060412 and ventricular septum morphogenesis and biological process this GO :0070411 and I-SMAD binding and molecular function this GO :0071560 and cellular response to transforming growth factor beta stimulus and biological process, SMAD7 and IDBG-3195 and ENSG00000101665 and 4092, SMAD7 and IDBG-644653 and ENSBTAG00000012441 and 535916, Smad7 and IDBG-158890 and ENSMUSG00000025880 and 17131, inhibitory cytoplasmic mediator activity, inhibitory cytoplasmic mediator activity and also this GO :0031625 : ubiquitin protein ligase binding and also this GO :0034713 : type I transforming growth factor beta receptor binding and also this GO :0044212 : transcription regulatory region DNA binding and also this GO :0046872 : metal ion binding and also this GO :0048185 : activin binding and also this GO :0070411 : I-SMAD binding, inhibitory cytoplasmic mediator activity and molecular function this GO :0031397 and negative regulation of protein ubiquitination and biological process this GO :0031398 and positive regulation of protein ubiquitination and biological process this GO :0031625 and ubiquitin protein ligase binding and molecular function this GO :0032436 and positive regulation of proteasomal ubiquitin-dependent protein catabolic process and biological process this GO :0032925 and regulation of activin receptor signaling pathway and biological process this GO :0033137 and negative regulation of peptidyl-serine phosphorylation and biological process this GO :0034333 and adherens junction assembly and biological process this GO :0034616 and response to laminar fluid shear stress and biological process this GO :0034629 and cellular protein complex localization and biological process this GO :0034713 and type I transforming growth factor beta receptor binding and molecular function this GO :0035556 and intracellular signal transduction and biological process this GO :0043234 and protein complex and cellular component this GO :0043433 and negative regulation of sequence-specific DNA binding transcription factor activity and biological process this GO :0044212 and transcription regulatory region DNA binding and molecular function this GO :0045087 and innate immune response and biological process this GO :0045892 and negative regulation of transcription, nuclei, this GO :0000122 and negative regulation of transcription from RNA polymerase II promoter and biological process this GO :0001657 and ureteric bud development and biological process this GO :0003700 and sequence-specific DNA binding transcription factor activity and molecular function this GO :0005515 and protein binding and molecular function this GO :0005518 and collagen binding and molecular function this GO :0005622 and intracellular and cellular component this GO :0005634 and nucleus and cellular component this GO :0005654 and nucleoplasm and cellular component this GO :0005667 and transcription factor complex and cellular component this GO :0005737 and cytoplasm and cellular component this GO :0005829 and cytosol and cellular component this GO :0005886 and plasma membrane and cellular component this GO :0005913 and cell-cell adherens junction and cellular component this GO :0006351 and transcription, this GO :0003700 : sequence-specific DNA binding transcription factor activity, this GO :0003700 : sequence-specific DNA binding transcription factor activity and also this GO :0005515 : protein binding and also this GO :0005518 : collagen binding and also this GO :0008013 : beta-catenin binding and also this GO :0030617 : transforming growth factor beta receptor, this GO :0005515 : protein binding, this GO :0005518 : collagen binding, this GO :0008013 : beta-catenin binding, this GO :0030617 : transforming growth factor beta receptor, this GO :0031625 : ubiquitin protein ligase binding, this GO :0034713 : type I transforming growth factor beta receptor binding, this GO :0044212 : transcription regulatory region DNA binding, this GO :0046872 : metal ion binding, this GO :0048185 : activin binding, this GO :0070411 : I-SMAD binding, transforming growth factor beta receptor, SMAD family member 7 |
| Identity: |
6773 |
| Gene: |
SMAD7 |
More about : SMAD7 |
| Long gene name: |
SMAD family member 7 |
| Synonyms gene: |
MADH8 MADH7 |
| Synonyms gene name: |
MAD, mothers against DPP homolog 7 (Drosophila) , mothers against decapentaplegic homolog 7 (Drosophila) SMAD |
| Locus: |
18q21, 1 |
| Discovery year: |
1997-08-22 |
| GenBank acession: |
AF010193 |
| Entrez gene record: |
4092 |
| Pubmed identfication: |
9256479 9730599 |
| RefSeq identity: |
NM_005904 |
| Classification: |
SMAD family |
| Havana BLAST/BLAT: |
OTTHUMG00000132655 |